» Articles » PMID: 35756044

Sophoridine Suppresses Herpes Simplex Virus Type 1 Infection by Blocking the Activation of Cellular PI3K/Akt and P38 MAPK Pathways

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2022 Jun 27
PMID 35756044
Authors
Affiliations
Soon will be listed here.
Abstract

Herpes simplex virus type 1 (HSV-1) is a ubiquitous and important human pathogen capable of causing significant clinical diseases ranging from skin damage to encephalitis, particularly in immunocompromised and neonatal hosts. Currently, widely used nucleoside analogs, including acyclovir and penciclovir, have some limitations in their use due to side effects and drug resistance. Herein, we report sophoridine's (SRI) dramatic inhibition of HSV-1 replication . SRI exhibited a remarkable inhibitory influence on HSV-1 virus-induced cytopathic effect and plaque formation, as well as on progeny viruses in Vero and HeLa cells, with selection indexes (SI) of 38.96 and 22.62, respectively. Moreover, SRI also considerably suppressed HSV-1 replication by hindering the expression of viral immediate-early (ICP0 and ICP22), early (ICP8 and TK), and late (gB and gD) genes and the expression of viral proteins ICP0, gB, and gD. We suggest that SRI can directly inactivate viral particles and block some stages in the life cycle of HSV-1 after adsorption. Further experiments showed that SRI downregulated the cellular PI3K/Akt signaling pathway and obstructed HSV-1 replication even more. Most importantly, SRI markedly repressed HSV-1-induced p38 MAPK pathway activation. Collectively, this natural bioactive alkaloid could be a promising therapeutic candidate against HSV-1 the modulation of cellular PI3K/Akt and p38 MAPK pathways.

Citing Articles

Acupuncture improves spatial learning and memory impairment caused by herpes simplex virus type-1 in rats through the p38 MAPK/CREB pathway.

Jin H, Huang R, Li Z, Liu M, Zhao N, Zhang H J Physiol Sci. 2024; 74(1):49.

PMID: 39363248 PMC: 11448188. DOI: 10.1186/s12576-024-00941-4.


Baicalin Inhibits FIPV Infection In Vitro by Modulating the PI3K-AKT Pathway and Apoptosis Pathway.

Cao Z, Ma N, Shan M, Wang S, Du J, Cheng J Int J Mol Sci. 2024; 25(18).

PMID: 39337417 PMC: 11431997. DOI: 10.3390/ijms25189930.


MiR-196a Promotes Lipid Deposition in Goat Intramuscular Preadipocytes by Targeting and Activating PI3K-Akt Pathway.

Yang Y, Zhang W, Li H, Xiang H, Zhang C, Du Z Cells. 2024; 13(17.

PMID: 39273029 PMC: 11394330. DOI: 10.3390/cells13171459.


Transcriptomic Analysis of PDCoV-Infected HIEC-6 Cells and Enrichment Pathways PI3K-Akt and P38 MAPK.

Jiang Y, Zhang G, Li L, Wang M, Chen J, Hao P Viruses. 2024; 16(4).

PMID: 38675921 PMC: 11054366. DOI: 10.3390/v16040579.


Ribavirin inhibits peste des petits ruminants virus proliferation .

Zhang W, Deng H, Liu Y, Chen S, Liu Y, Zhao Y Vet Med (Praha). 2024; 68(12):464-476.

PMID: 38303996 PMC: 10828777. DOI: 10.17221/56/2023-VETMED.


References
1.
Shen M, Ma N, Li M, Liu Y, Chen T, Wei F . Antiviral Properties of Nanoparticles on Herpes Simplex Virus Type I and . Front Pharmacol. 2019; 10:959. PMC: 6737004. DOI: 10.3389/fphar.2019.00959. View

2.
Luo Z, Kuang X, Zhou Q, Yan C, Li W, Gong H . Inhibitory effects of baicalein against herpes simplex virus type 1. Acta Pharm Sin B. 2020; 10(12):2323-2338. PMC: 7745058. DOI: 10.1016/j.apsb.2020.06.008. View

3.
Sloan D, Jerome K . Herpes simplex virus remodels T-cell receptor signaling, resulting in p38-dependent selective synthesis of interleukin-10. J Virol. 2007; 81(22):12504-14. PMC: 2169026. DOI: 10.1128/JVI.01111-07. View

4.
Liu X, Li Q, Dowdell K, Fischer E, Cohen J . Varicella-Zoster virus ORF12 protein triggers phosphorylation of ERK1/2 and inhibits apoptosis. J Virol. 2012; 86(6):3143-51. PMC: 3302337. DOI: 10.1128/JVI.06923-11. View

5.
Caggiu E, Paulus K, Arru G, Piredda R, Sechi G, Sechi L . Humoral cross reactivity between α-synuclein and herpes simplex-1 epitope in Parkinson's disease, a triggering role in the disease?. J Neuroimmunol. 2016; 291:110-4. DOI: 10.1016/j.jneuroim.2016.01.007. View